scholarly article | Q13442814 |
P819 | ADS bibcode | 2015NatCo...6.6614P |
P356 | DOI | 10.1038/NCOMMS7614 |
P932 | PMC publication ID | 4374153 |
P698 | PubMed publication ID | 25782711 |
P5875 | ResearchGate publication ID | 273786009 |
P50 | author | David R Greaves | Q40643814 |
Eileen McNeill | Q41774481 | ||
Regent Lee | Q42315557 | ||
Asif J Iqbal | Q47424322 | ||
Keith Channon | Q56420294 | ||
Elena Stylianou | Q90681540 | ||
Daniel Regan-Komito | Q92527301 | ||
Gillian Douglas | Q94461434 | ||
Ashley Hale | Q114399415 | ||
P2093 | author name string | Jyoti Patel | |
Joseph de Bono | |||
P2860 | cites work | CD40 and its ligand in atherosclerosis. | Q36812081 |
Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention | Q36824150 | ||
An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. | Q37452257 | ||
Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling | Q37709733 | ||
Chemokines in atherosclerosis: proceedings resumed | Q38179327 | ||
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice | Q41998884 | ||
Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? | Q42772706 | ||
B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice | Q44212443 | ||
Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice | Q44680905 | ||
Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells | Q44823348 | ||
Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice | Q45240037 | ||
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
Identification of new genes differentially expressed in coronary artery disease by expression profiling | Q47709919 | ||
Novel candidate genes in unstable areas of human atherosclerotic plaques. | Q51585538 | ||
Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. | Q52005765 | ||
Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. | Q54240315 | ||
Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. | Q54412663 | ||
Chapter 17 Zymosan‐Induced Peritonitis as a Simple Experimental System for the Study of Inflammation | Q57665534 | ||
Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice | Q58149069 | ||
Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice | Q61386204 | ||
Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation | Q80774851 | ||
Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis | Q24568066 | ||
Shared and distinct genetic variants in type 1 diabetes and celiac disease | Q24623113 | ||
Newly identified genetic risk variants for celiac disease related to the immune response | Q24654340 | ||
Structural diversity in the RGS domain and its interaction with heterotrimeric G protein -subunits | Q27650447 | ||
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines | Q28564355 | ||
Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent | Q30440410 | ||
The Murine Angiotensin II-Induced Abdominal Aortic Aneurysm Model: Rupture Risk and Inflammatory Progression Patterns | Q30501012 | ||
Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice | Q33236495 | ||
Statins stimulate RGS-regulated ERK 1/2 activation in human calcified and stenotic aortic valves | Q33356824 | ||
Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice | Q33738515 | ||
Multiple sclerosis susceptibility alleles in African Americans. | Q33892035 | ||
B cell depletion reduces the development of atherosclerosis in mice | Q34044387 | ||
Regulators of G-protein signalling as new central nervous system drug targets. | Q34139169 | ||
Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression | Q34150874 | ||
Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members | Q34475398 | ||
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice | Q34789613 | ||
Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice | Q34790053 | ||
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression | Q34876397 | ||
Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential | Q35195555 | ||
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques | Q35250952 | ||
Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction | Q35523846 | ||
The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques | Q35685440 | ||
Multi-tasking RGS proteins in the heart: the next therapeutic target? | Q36061193 | ||
T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse | Q36142970 | ||
Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice | Q36732984 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ruptured aortic aneurysm | Q55072931 |
P304 | page(s) | 6614 | |
P577 | publication date | 2015-03-18 | |
P1433 | published in | Nature Communications | Q573880 |
P1476 | title | RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling | |
P478 | volume | 6 |
Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
Q61818107 | Biliverdin administration regulates the microRNA-mRNA expressional network associated with neuroprotection in cerebral ischemia reperfusion injury in rats |
Q57178844 | Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease |
Q89543967 | Hematopoietic cell-derived RELMα regulates hookworm immunity through effects on macrophages |
Q39239967 | Monocytes and macrophages in abdominal aortic aneurysm |
Q90279451 | Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells |
Q38644453 | R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity |
Q59358337 | Regulator of G protein signaling 5 restricts neutrophil chemotaxis and trafficking |
Q88493279 | Regulators of G protein signaling in cardiovascular function during pregnancy |
Q38806373 | The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity |
Q52766696 | Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate. |
Q52719416 | Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control. |
Search more.